Genetics for Health Sciences
Master the molecular and classical genetics concepts that underpin modern clinical practice — from DNA replication and gene expression to inherited disease, epigenetics, and pharmacogenomics.
DNA Structure and Replication
The molecular blueprint and how it is copied
DNA (deoxyribonucleic acid) is a double helix composed of two antiparallel strands. Each strand is a polymer of nucleotides. A nucleotide consists of three components: a phosphate group, a deoxyribose sugar, and one of four nitrogenous bases (Adenine, Thymine, Guanine, Cytosine). The two strands are held together by hydrogen bonds between complementary base pairs: A pairs with T (2 hydrogen bonds) and G pairs with C (3 hydrogen bonds). G-C pairs are stronger — higher G-C content increases the melting temperature of DNA.
Nucleotide Components
Phosphate group — forms the negatively charged backbone.
Deoxyribose — the five-carbon sugar distinguishing DNA from RNA (which has ribose).
Nitrogenous base — A, T, G, or C. Encodes genetic information.
Base Pairing Rules
A ↔ T: 2 hydrogen bonds (weaker).
G ↔ C: 3 hydrogen bonds (stronger).
Strands are antiparallel: one runs 5′→3′, the complementary strand runs 3′→5′.
Prokaryotes vs. Eukaryotes
Bacteria have one circular chromosome and one origin of replication.
Humans have 23 pairs of linear chromosomes and thousands of replication origins to complete copying in hours.
The Four Key Steps of DNA Replication
Replication Errors, Mutations, and Cancer
DNA polymerase makes roughly 1 error per 10⁹ nucleotides copied due to proofreading and mismatch repair mechanisms. Despite this extraordinary accuracy, errors that escape repair become permanent mutations. Cancer arises when mutations accumulate in genes controlling cell division (oncogenes, tumor suppressors). Chemotherapy drugs exploit the same vulnerability: they preferentially target rapidly dividing cells because those cells undergo the most DNA replication.
Allied Health Relevance
Nursing: Understanding DNA replication underpins teaching patients about chemotherapy side effects (bone marrow suppression, mucositis) — these target organs have rapidly dividing cells. MLT: PCR relies on the same base-pairing and strand synthesis principles to amplify specific DNA sequences for diagnostics. Respiratory Therapy: Alpha-1 antitrypsin deficiency is a single-gene mutation causing premature emphysema — genetic screening guides early intervention. Paramedic: Some hereditary arrhythmia syndromes (Long QT) require specific medication avoidance in the field.
Gene Expression — Transcription and Translation
From DNA sequence to functional protein
Gene expression is the process of using the information in DNA to build proteins. It occurs in two major stages: transcription (DNA → mRNA) and translation (mRNA → protein). In eukaryotes, transcription occurs in the nucleus and translation in the cytoplasm. This spatial separation allows extensive processing of the RNA transcript before it is translated.
Transcription
RNA polymerase binds the promoter sequence and reads the template strand 3′→5′, synthesizing mRNA 5′→3′ using ribonucleotides (A, U, G, C — uracil replaces thymine). Transcription continues to the terminator sequence. The initial transcript is pre-mRNA (hnRNA).
RNA Processing (Eukaryotes)
5′ cap (7-methylguanosine) — protects mRNA from degradation and facilitates ribosome binding.
Poly-A tail — hundreds of adenines added at 3′ end, increases stability and export.
Splicing — spliceosomes remove introns (non-coding sequences) and join exons (coding sequences). A single gene can produce multiple proteins by alternative splicing.
Translation
Ribosomes (assembled from rRNA and proteins) read mRNA in codons (triplets of nucleotides). Each codon is recognized by a tRNA carrying a complementary anticodon and the corresponding amino acid. A peptide bond forms between adjacent amino acids. Three stop codons (UAA, UAG, UGA) terminate translation. The genetic code is degenerate: 61 sense codons encode 20 amino acids, so multiple codons can specify the same amino acid.
Post-Translational Modification and Gene Regulation
Gene expression is tightly regulated. Promoter sequences upstream of a gene recruit RNA polymerase. Transcription factors are proteins that bind promoters or enhancers to activate or repress transcription. Enhancers can be thousands of base pairs away from the gene they regulate. This layered regulation means identical DNA can produce very different proteins in different cell types — a neuron and a hepatocyte carry the same genome but express very different protein repertoires.
Gene Expression Quick Check
1/5RNA polymerase reads the DNA template strand in which direction?
Allied Health Relevance
Nursing: Many targeted cancer therapies (e.g., imatinib in CML) block proteins that are overexpressed due to gene translocation — understanding gene expression explains why these drugs work. MLT: RT-PCR (reverse transcriptase PCR) converts mRNA back to cDNA to quantify gene expression levels, used in viral load testing (HIV, COVID-19) and cancer diagnostics. Respiratory Therapy: Inhaled corticosteroids work partly by binding glucocorticoid receptors that act as transcription factors, altering gene expression in airway cells. Paramedic: Opioid receptor gene variants influence analgesic response — relevant for pain management protocols.
Mutations and Clinical Consequences
When the genetic code changes
A mutation is any heritable change in the nucleotide sequence of DNA. Mutations range from single base-pair changes (point mutations) to large chromosomal rearrangements. Their clinical impact depends on which gene is affected, which cell type carries the mutation, and whether the mutation is in the germline (inherited) or somatic (acquired during life).
Four Major Mutation Types with Clinical Examples
Sickle Cell Disease — A Molecular Case Study
A single A→T transversion in codon 6 of the HBB (beta-globin) gene replaces glutamic acid (hydrophilic) with valine (hydrophobic). Under low-oxygen conditions, the mutant hemoglobin S polymerizes into rigid fibers, deforming red blood cells into a sickle shape. Sickled cells obstruct small vessels (vaso-occlusive crisis), lyse prematurely (hemolytic anemia), and impair oxygen delivery. This illustrates how a single nucleotide change can have organ-wide consequences.
DNA Repair Mechanisms
Mismatch repair (MMR): corrects replication errors — mutations in MLH1/MSH2 cause Lynch syndrome (hereditary non-polyposis colorectal cancer).
Nucleotide excision repair (NER): removes bulky lesions from UV radiation — loss causes xeroderma pigmentosum.
Base excision repair (BER): removes chemically modified single bases.
BRCA1/BRCA2: involved in homologous recombination repair of double-strand breaks — germline mutations confer up to 70–80% lifetime breast cancer risk.
Germline vs. Somatic Mutation — Why the Distinction Matters
Somatic mutations occur in body cells after fertilization and are not passed to offspring. They accumulate over a lifetime and are the primary driver of cancer. Germline mutations occur in eggs or sperm and are inherited by every cell of the offspring. A BRCA1 mutation inherited from a parent is present in every cell of the child, dramatically elevating lifetime cancer risk. This distinction determines who in a family needs genetic counseling and risk-reduction strategies.
Allied Health Relevance
Nursing: Patients with sickle cell disease require specialized pain management, hydration, and education about triggers (cold, dehydration, hypoxia). MLT: Molecular labs perform PCR-based testing for sickle cell, fragile X, and BRCA mutations. Understanding mutation types guides test selection. Respiratory Therapy: CF is caused by mutations in the CFTR gene (most commonly ΔF508, a phenylalanine deletion). CFTR modulator drugs (ivacaftor, elexacaftor) are mutation-specific. Paramedic: A patient with known sickle cell presenting with severe pain, fever, or shortness of breath needs urgent hospital transport.
Mendelian Genetics
Patterns of inheritance and Punnett squares
Gregor Mendel's experiments with pea plants established the foundational laws of inheritance. While molecular genetics has added great complexity, Mendelian principles accurately predict inheritance patterns for thousands of single-gene (Mendelian) disorders relevant to clinical practice.
Mendel's Laws
Law of Segregation: each individual carries two alleles for each trait; alleles separate during gamete formation so each gamete carries only one allele.
Law of Independent Assortment: genes on different (non-homologous) chromosomes are inherited independently of each other, producing a 9:3:3:1 ratio in dihybrid crosses.
Essential Vocabulary
Gene: DNA sequence encoding a functional product.
Allele: a version of a gene.
Locus: chromosomal location of a gene.
Genotype: allele combination (e.g., Aa).
Phenotype: observable trait.
Homozygous: two identical alleles (AA or aa).
Heterozygous: two different alleles (Aa).
Monohybrid Cross — 3:1 Phenotype Ratio
Cross two heterozygotes (Aa × Aa): offspring are AA (1), Aa (2), aa (1). Since A is dominant, phenotype ratio = 3 dominant : 1 recessive. ABO blood type adds complexity: both A and B alleles are co-dominant over O, and A and B are co-dominant with each other, producing four phenotypes from three alleles.
Autosomal Recessive Disorders
Both alleles must be mutant to show disease. Carriers (one mutant allele) are usually unaffected.
Cystic fibrosis: CFTR mutations; 1 in 25 Caucasians are carriers.
PKU: PAH deficiency; newborn screening and low-phenylalanine diet prevent intellectual disability.
Sickle cell: HBB p.Glu6Val; high carrier frequency in malaria-endemic regions.
Autosomal Dominant Disorders
One mutant allele is sufficient to cause disease. Affected individuals are usually heterozygous.
Huntington disease: CAG repeat expansion; 100% penetrant, onset typically 30–50s.
Marfan syndrome: FBN1 mutation; tall stature, aortic root dilation risk.
Familial hypercholesterolemia: LDL receptor mutations; premature cardiovascular disease.
X-Linked Inheritance — Why Males Are More Affected
Males have one X chromosome (XY) and one Y chromosome. Females have two X chromosomes (XX). X-linked recessive disorders affect males almost exclusively because males have only one X: if it carries the mutant allele, no second copy can compensate. Females with one mutant and one normal X are carriers — they typically are unaffected but have a 50% chance of passing the mutant allele to each child. This explains why hemophilia A, Duchenne muscular dystrophy, and red-green color blindness are far more common in males.
Match the Inheritance Pattern to the Disease
Terms
Definitions
Mendelian Genetics Quick Check
1/4Two carriers of an autosomal recessive disorder have a child. What is the probability the child will be affected?
Allied Health Relevance
Nursing: Recognizing inheritance patterns allows nurses to provide accurate family counseling and identify relatives who may need genetic testing. Pedigree analysis is a nursing assessment skill. MLT: Blood type genotyping and paternity testing use allele-specific PCR based on Mendelian principles. Respiratory Therapy: CF carrier testing is recommended before pregnancy; understanding recessive inheritance helps explain risk to families. Paramedic: Marfan syndrome patients are at risk for aortic dissection — tall stature with chest pain requires urgent assessment.
Chromosomes and Cell Division
Mitosis, meiosis, and chromosomal disorders
Humans have 46 chromosomes (2n = 46), arranged in 23 homologous pairs. Chromosomes 1–22 are autosomes; pair 23 is the sex chromosomes (XX female, XY male). A karyotype is a visual display of an individual's chromosomes arranged by size and banding pattern, used to detect large chromosomal abnormalities.
Mitosis — Somatic Cell Division
Produces 2 genetically identical diploid (2n) daughter cells. Phases: Prophase (chromosomes condense), Metaphase (line up at cell equator), Anaphase (chromatids pulled to poles), Telophase (nuclear envelopes reform) — mnemonic PMAT. DNA replication occurs in S phase of interphase (G1-S-G2-M cycle) before mitosis begins.
Meiosis — Gamete Formation
Two successive divisions (Meiosis I and II) produce 4 haploid (n=23) gametes from one diploid cell. Crossing over in Prophase I: homologous chromosomes exchange segments, generating genetic diversity. Meiosis I separates homologous chromosomes. Meiosis II separates sister chromatids (like mitosis).
Chromosomal Aneuploidies — Clinical Summary
Trisomy 21 (Down syndrome): extra chr 21; intellectual disability, hypotonia, cardiac defects (AV canal), increased Alzheimer's risk. ~1:700 live births.
Monosomy X (Turner syndrome, 45,X): missing one X; short stature, gonadal dysgenesis, webbed neck, coarctation of aorta. Only monosomy compatible with life.
Trisomy 18 (Edwards syndrome): extra chr 18; severe intellectual disability, rocker-bottom feet, overlapping fingers, 90% die within first year.
Trisomy 13 (Patau syndrome): extra chr 13; holoprosencephaly, midline facial defects, polydactyly; median survival days to weeks.
Nondisjunction and Why Maternal Age Increases Risk
Nondisjunction is the failure of chromosomes (or chromatids) to separate properly during meiosis or mitosis. In meiosis, it produces gametes with an extra or missing chromosome. When such a gamete is fertilized, the zygote has a trisomy (three copies) or monosomy (one copy) of that chromosome. Trisomy 21 (Down syndrome) is the most common, occurring in approximately 1 in 700 live births. Maternal age is the strongest risk factor because oocytes are arrested in prophase I of meiosis from before birth — a 40-year-old's oocytes have been arrested for four decades, during which molecular errors in the meiotic spindle accumulate.
Allied Health Relevance
Nursing: Nurses caring for patients with trisomy 21 must understand associated cardiac defects, thyroid disease, and atlantoaxial instability. Family-centered care includes supporting parents at diagnosis. MLT: Cytogenetics labs perform karyotyping and FISH (fluorescence in situ hybridization) to detect chromosomal abnormalities in blood, bone marrow, and chorionic villus samples. Respiratory Therapy: Patients with trisomy 21 have hypotonia and may require prolonged ventilatory support. Upper airway anatomy differences complicate intubation. Paramedic: Turner syndrome patients may have undiagnosed aortic coarctation causing hypertension in the arms with weak femoral pulses.
Epigenetics and Gene Regulation
Heritable changes in expression without DNA sequence changes
Epigenetics refers to heritable changes in gene expression that do not involve alterations to the underlying DNA sequence. These changes are mediated by chemical modifications of DNA and histones, and by small regulatory RNA molecules. Epigenetic changes explain how identical twins can develop different diseases, how fetal environment influences adult health, and why cancer involves both genetic and epigenetic dysregulation.
DNA Methylation
A methyl group (–CH₃) is added to cytosine residues, typically at CpG dinucleotides, by DNA methyltransferase enzymes. Methylation of gene promoters generally silences gene expression by blocking transcription factor binding and recruiting repressor proteins. DNA methylation patterns are copied during DNA replication, making them heritable.
Histone Modification
DNA is wrapped around histone proteins to form chromatin. Chemical modifications to histone tails alter how tightly DNA is packaged.
Acetylation (by HATs): relaxes chromatin, activates transcription — "open" euchromatin.
Deacetylation (by HDACs): compacts chromatin, silences genes — HDAC inhibitors are used as cancer drugs.
Methylation: context-dependent; H3K4me3 activates, H3K27me3 silences.
Genomic Imprinting
Genomic imprinting: only one parental allele is expressed, determined by which parent it was inherited from. The chromosome 15q11-q13 region is imprinted differently depending on its parental origin.
Prader-Willi syndrome: deletion of paternal chromosome 15q11-q13 (or maternal uniparental disomy). Features: hypotonia, hyperphagia, intellectual disability.
Angelman syndrome: deletion of maternal chromosome 15q11-q13 (or paternal UPD). Features: severe intellectual disability, seizures, happy demeanor.
miRNA Regulation
MicroRNAs (miRNAs) are short (~22 nucleotide) non-coding RNA molecules that bind complementary sequences in mRNA, leading to mRNA degradation or translational repression. A single miRNA can regulate hundreds of genes. Dysregulation of miRNAs contributes to cancer and cardiovascular disease. miRNAs circulate in the bloodstream and are being investigated as diagnostic biomarkers and therapeutic targets.
How Environment Changes Gene Expression — Clinical Significance
Environmental exposures leave lasting marks on the epigenome. Folate (vitamin B9) is required for one-carbon metabolism and DNA methylation; deficiency during early pregnancy causes neural tube defects. Chronic psychosocial stress alters glucocorticoid receptor methylation patterns in the brain, with effects that can persist for years. Exercise induces histone modifications that open chromatin at metabolic gene loci. These findings are clinically significant because, unlike DNA sequence mutations, many epigenetic changes are reversible — opening therapeutic possibilities.
Cancer Epigenetics
In cancer, tumor suppressor genes are frequently silenced by hypermethylation of their promoters. This is functionally equivalent to a mutation but does not change the DNA sequence — the gene is present but cannot be expressed. DNMT inhibitors (azacitidine, decitabine) are approved for myelodysplastic syndrome and act by removing aberrant methylation marks, re-expressing silenced tumor suppressor genes.
Allied Health Relevance
Nursing: Epigenetics supports the value of lifestyle interventions (diet, exercise, stress reduction) at a molecular level — a powerful patient education tool. MLT: Bisulfite sequencing and methylation-specific PCR detect aberrant DNA methylation in cancer diagnostics. Respiratory Therapy: Early-life exposures to tobacco smoke cause epigenetic changes in airway epithelium that persist into adulthood, underlying the clinical rationale for strict smoke-free environments in neonatal care. Paramedic: Maternal drug exposure causes epigenetic changes in the developing fetal brain — relevant context for neonatal opioid withdrawal syndrome calls.
Pharmacogenomics and Clinical Genetics
How genetic variation shapes drug response and disease risk
Pharmacogenomics (PGx) is the study of how an individual's genetic makeup affects their response to drugs. Genetic variants in drug-metabolizing enzymes, drug transporters, and drug targets explain a significant proportion of variability in drug efficacy and adverse drug reactions.
CYP450 Enzyme Polymorphisms
Cytochrome P450 (CYP) enzymes metabolize approximately 75% of marketed drugs. Genetic variants create four metabolizer phenotypes: poor (PM), intermediate (IM), normal/extensive (NM/EM), and ultrarapid (UM).
CYP2D6 — codeine/morphine: Poor metabolizers cannot convert codeine to morphine (no analgesia, codeine is a prodrug). Ultrarapid metabolizers produce toxic morphine concentrations — FDA black box warning against codeine in breastfeeding mothers who are UM (neonatal morphine toxicity and death reported).
CYP2C19 — clopidogrel: Clopidogrel is a prodrug requiring CYP2C19 activation to its active thiol metabolite. Poor metabolizers (common in East Asian populations) cannot activate clopidogrel — diminished antiplatelet effect → stent thrombosis risk. FDA added a black box warning. Prasugrel or ticagrelor are alternatives.
HLA Typing and Drug Hypersensitivity
HLA (Human Leukocyte Antigen) genes encode proteins that present peptide antigens to immune cells. Certain HLA variants cause immune-mediated severe adverse drug reactions.
HLA-B*5701 and abacavir: HIV antiretroviral. Carriers of this allele develop a severe hypersensitivity reaction (fever, rash, multi-organ involvement) upon abacavir exposure. Prospective HLA-B*5701 screening before prescribing has virtually eliminated this reaction. FDA-mandated testing.
HLA-B*1502 and carbamazepine: Antiepileptic. Carriers (predominantly Southeast Asian populations) are at dramatically elevated risk for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) — life-threatening skin reactions. FDA recommends testing in at-risk populations before initiation.
Cancer Susceptibility Genes
BRCA1 / BRCA2: Tumor suppressor genes encoding DNA repair proteins. Pathogenic germline variants confer ~70–80% lifetime risk of breast cancer and 40–60% ovarian cancer risk (BRCA1). Risk management options: intensive surveillance, chemoprevention (tamoxifen), risk-reducing salpingo-oophorectomy, prophylactic mastectomy. Cascade testing of relatives is recommended.
APOE ε4: The APOE ε4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease. Carrying one ε4 allele increases risk ~3-fold; two copies ~12-fold. It is not deterministic — many ε4/ε4 individuals do not develop Alzheimer's. Its role in cholesterol metabolism and neuroinflammation is under active investigation.
Genetic Testing Modalities
Karyotype: visualizes all chromosomes; detects aneuploidies and large structural rearrangements.
FISH: fluorescently labeled probes hybridize to specific chromosomal loci; detects known deletions/duplications/translocations rapidly.
PCR: amplifies specific DNA sequences; used for single-gene disorder testing, pathogen detection, and mutation confirmation.
Microarray (chromosomal SNP array): detects copy number variants (CNVs) across the genome at higher resolution than karyotype.
Whole exome sequencing (WES): sequences all protein-coding regions (~1–2% of genome but ~85% of known disease-causing variants).
Whole genome sequencing (WGS): sequences entire genome including non-coding regions; highest sensitivity, most complex interpretation.
Prenatal and Newborn Genetic Screening
Cell-free DNA (NIPT): analyzes fetal DNA circulating in maternal blood; screens for trisomy 21, 18, 13, and sex chromosome aneuploidies from 10 weeks gestation; high sensitivity/specificity, non-invasive but a screening test — positive results require diagnostic confirmation.
Amniocentesis: 15–20 weeks; samples amniotic fluid containing fetal cells; diagnostic (karyotype, FISH, microarray); ~0.1–0.3% procedure-related loss risk.
Chorionic villus sampling (CVS): 10–13 weeks; samples placental tissue; earlier diagnosis; similar loss risk to amniocentesis.
Newborn screening: Guthrie card heel-stick blood spot tests all newborns for dozens of metabolic, endocrine, and hematologic disorders (PKU, congenital hypothyroidism, galactosemia, sickle cell, CAH, SCID). Early treatment for PKU (low-phenylalanine diet) and congenital hypothyroidism (levothyroxine) prevents irreversible intellectual disability.
Implementing PGx — What the Literature Shows
Genetic testing is increasingly standard before prescribing certain drugs. The FDA recommends HLA-B*5701 testing before abacavir (an HIV antiretroviral) because carriers have a nearly 100% risk of a severe hypersensitivity reaction. CYP2C19 testing guides clopidogrel dosing after coronary stents — poor metabolizers cannot activate the prodrug and are at elevated risk of in-stent thrombosis. The CPIC (Clinical Pharmacogenomics Implementation Consortium) publishes freely available guidelines translating genotype into prescribing recommendations for practicing clinicians.
Pharmacogenomics and Clinical Genetics Quiz
1/5A breastfeeding mother who is a CYP2D6 ultrarapid metabolizer is prescribed codeine for postoperative pain. The primary concern for her infant is:
Allied Health Relevance
Nursing: Nurses are increasingly the point of care for PGx result communication. Understanding that a 'poor metabolizer' result for CYP2C19 has direct prescribing implications for antiplatelet therapy empowers nurses to flag these results. MLT: Clinical molecular labs perform CYP450 genotyping, HLA typing, and BRCA sequencing. Understanding the clinical context improves result reporting. Respiratory Therapy: CFTR mutation-specific drugs (elexacaftor/tezacaftor/ivacaftor) require molecular confirmation of eligible mutations — a direct intersection of genetics and respiratory pharmacotherapy. Paramedic: Awareness that some patients carry pharmacogenomic information on their person (medical alert cards) can guide medication choices during out-of-hospital emergencies.
Genetics — Comprehensive Module Quiz (10 Questions)
1/10Which enzyme is responsible for unwinding the DNA double helix during replication?
Pre-nursing comprehensive review
1/20Which organelle contains its own DNA and is inherited exclusively from the mother?